Filing Details
- Accession Number:
- 0001193125-18-042861
- Form Type:
- 13G Filing
- Publication Date:
- 2018-02-13 17:17:04
- Filed By:
- Squadron Capital Llc
- Company:
- Orthopediatrics Corp (NASDAQ:KIDS)
- Filing Date:
- 2018-02-13
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Squadron Capital | 0 | 5,378,441 | 0 | 5,378,441 | 5,378,441 | 42.4% |
| Squadron Capital Holdings | 0 | 5,378,441 | 0 | 5,378,441 | 5,378,441 | 42.4% |
| Harry B. Rosenberg, not individually, but solely as co-trustee of each of the trusts listed in Item | 0 | 5,378,441 | 0 | 5,378,441 | 5,378,441 | 42.4% |
| Charles E. Dobrusin, not individually, but solely as co-trustee of each of the trusts listed in Item | 0 | 5,378,441 | 0 | 5,378,441 | 5,378,441 | 42.4% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
OrthoPediatrics Corp.
(Name of Issuer)
Common Stock, par value $0.00025 per share
(Title of Class of Securities)
68752L100
(CUSIP Number)
December 31, 2017
(Date of Event That Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1 (b)
☐ Rule 13d-1 (c)
☒ Rule 13d-1 (d)
| * | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 2 of 11 |
| 1. | NAMES OF REPORTING PERSONS
Squadron Capital LLC | |||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐
| |||||
| 3. | SEC USE ONLY
| |||||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER
0 | ||||
| 6. | SHARED VOTING POWER
5,378,441(1) | |||||
| 7. | SOLE DISPOSITIVE POWER
0 | |||||
| 8. | SHARED DISPOSITIVE POWER
5,378,441(1) | |||||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,378,441(1) | |||||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐ | |||||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
42.4%(2) | |||||
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO | |||||
| (1) | Includes 1,340 shares of Common Stock, par value $0.00025 per share (the Common Stock), of OrthoPediatrics Corp. (the Issuer) which Squadron Capital LLC has the right to acquire pursuant to outstanding options which are immediately exercisable. |
| (2) | Based on 12,697,991 shares of Common Stock outstanding as of November 9, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 and 1,340 shares of Common Stock issuable upon exercise of outstanding options held by Squadron Capital LLC. |
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 3 of 11 |
| 1. | NAMES OF REPORTING PERSONS
Squadron Capital Holdings LLC | |||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐
| |||||
| 3. | SEC USE ONLY
| |||||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER
0 | ||||
| 6. | SHARED VOTING POWER
5,378,441(1) | |||||
| 7. | SOLE DISPOSITIVE POWER
0 | |||||
| 8. | SHARED DISPOSITIVE POWER
5,378,441(1) | |||||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,378,441(1) | |||||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐ | |||||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
42.4%(2) | |||||
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO | |||||
| (1) | Includes 1,340 shares of Common Stock, par value $0.00025 per share (the Common Stock), of OrthoPediatrics Corp. (the Issuer) which Squadron Capital LLC has the right to acquire pursuant to outstanding options which are immediately exercisable. |
| (2) | Based on 12,697,991 shares of Common Stock outstanding as of November 9, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 and 1,340 shares of Common Stock issuable upon exercise of outstanding options held by Squadron Capital LLC. |
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 4 of 11 |
| 1. | NAMES OF REPORTING PERSONS
Harry B. Rosenberg, not individually, but solely as co-trustee of each of the trusts listed in Item 4 of this Report | |||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐
| |||||
| 3. | SEC USE ONLY
| |||||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION
USA | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER
0 | ||||
| 6. | SHARED VOTING POWER
5,378,441(1) | |||||
| 7. | SOLE DISPOSITIVE POWER
0 | |||||
| 8. | SHARED DISPOSITIVE POWER
5,378,441(1) | |||||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,378,441(1) | |||||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐ | |||||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
42.4%(2) | |||||
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN | |||||
| (1) | Includes 1,340 shares of Common Stock, par value $0.00025 per share (the Common Stock) of OrthoPediatrics Corp. (the Issuer) which Squadron Capital LLC has the right to acquire pursuant to outstanding options which are immediately exercisable. |
| (2) | Based on 12,697,991 shares of Common Stock outstanding as of November 9, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 and 1,340 shares of Common Stock issuable upon exercise of outstanding options held by Squadron Capital LLC. |
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 5 of 11 |
| 1. | NAMES OF REPORTING PERSONS
Charles E. Dobrusin, not individually, but solely as co-trustee of each of the trusts listed in Item 4 of this Report | |||||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐
| |||||
| 3. | SEC USE ONLY
| |||||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION
USA | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER
0 | ||||
| 6. | SHARED VOTING POWER
5,378,441(1) | |||||
| 7. | SOLE DISPOSITIVE POWER
0 | |||||
| 8. | SHARED DISPOSITIVE POWER
5,378,441(1) | |||||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,378,441(1) | |||||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐ | |||||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
42.4%(2) | |||||
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN | |||||
| (1) | Includes 1,340 shares of Common Stock, par value $0.00025 per share (the Common Stock), of OrthoPediatrics Corp. (the Issuer) which Squadron Capital LLC has the right to acquire pursuant to outstanding options which are immediately exercisable. |
| (2) | Based on 12,697,991 shares of Common Stock outstanding as of November 9, 2017, as set forth in the Issuers Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 and 1,340 shares of Common Stock issuable upon exercise of outstanding options held by Squadron Capital LLC. |
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 6 of 11 |
Item 1(a). Name of Issuer:
OrthoPediatrics Corp. (the Issuer)
Item 1(b). Address of Issuers Principal Executive Offices:
2850 Frontier Drive
Warsaw, IN 46582
Item 2(a).
Name of Person(s) Filing:
Squadron Capital LLC
Squadron Capital Holdings LLC
Harry B. Rosenberg, not individually, but solely as co-trustee of each of the trusts listed in Item 4 of this Report
Charles E. Dobrusin, not individually, but solely as co-trustee of each of the trusts listed in Item 4 of this Report
Item 2(b).
Address of Principal Business Office, or, if None, Residence:
Squadron Capital LLC
Squadron Capital Holdings LLC
18 Hartford Avenue
PO Box 223
Granby, CT 06035
Harry B. Rosenberg
Charles E. Dobrusin
10 S. Wacker Drive., Suite 4000
Chicago, IL 60606
Item 2(c).
Citizenship:
Squadron Capital LLC is a Delaware limited liability company.
Squadron Capital Holdings LLC is a Delaware limited liability company.
Harry B. Rosenberg is US citizen.
Charles E. Dobrusin is a US citizen.
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 7 of 11 |
Item 2(d).
Title of Class of Securities:
Common Stock, par value $0.00025 per share
Item 2(e).
CUSIP Number:
68752L100
| Item 3. | If This Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a: |
| (a) | ☐ | Broker or dealer registered under section 15 of the Act ( 15 U.S.C. 78o); | ||
| (b) | ☐ | Bank as defined in section 3(a)(6) of the Act ( 15 U.S.C. 78c); | ||
| (c) | ☐ | Insurance company as defined in section 3(a)(19) of the Act ( 15 U.S.C. 78c); | ||
| (d) | ☐ | Investment company registered under section 8 of the Investment Company Act of 1940 ( 15 U.S.C 80a-8); | ||
| (e) | ☐ | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | ||
| (f) | ☐ | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | ||
| (g) | ☐ | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | ||
| (h) | ☐ | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act ( 12 U.S.C. 1813); | ||
| (i) | ☐ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 ( 15 U.S.C. 80a-3); | ||
| (j) | ☐ | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); | ||
| (k) | ☐ | Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: | ||
Not Applicable
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 8 of 11 |
| Item 4. | Ownership: |
The information required by Items 4(a) (c) is set forth in Rows (5) (11) of the cover page for each Reporting Person and is incorporated herein by reference.
Squadron Capital LLC is the record owner of 5,378,441 shares of Common Stock of the Issuer reported in this Schedule 13G, including 1,340 shares of Commons Stock issuable upon exercise of options to purchase shares of Common Stock. Squadron Capital LLC is managed by a management committee, the members of which are David R. Pelizzon, Jennifer N. Pritzker, Harry B. Rosenberg and Charles E. Dobrusin. Mr. Pelizzon is a director of the Issuer and owns 10,000 shares of Common Stock. Squadron Capital LLC is a wholly-owned subsidiary of Squadron Capital Holdings LLC.
Squadron Capital Holdings LLC is owned by the following trusts:
JNP Parachute Mirror Trust L Harry B. Rosenberg and Charles E. Dobrusin, Trustees;
F.L.P. Trust #15M2 Harry B. Rosenberg and Charles E. Dobrusin, Trustees;
JNP 2010 P.G. Trust Harry B. Rosenberg and Charles E. Dobrusin, Trustees; and
F.L.P. #15 M2 Parachute Trust Harry B. Rosenberg and Charles E. Dobrusin, Trustees
As trustees of the trusts listed above, Mr. Rosenberg and Mr. Dobrusin may be deemed beneficial owners of the shares held by Squadron Capital LLC insofar as they may be deemed to share the power to direct the voting or disposition of such shares. Neither the filing of this Schedule 13G, any amendment hereto, nor any of their respective contents shall be deemed to constitute an admission that any such individuals is, the beneficial owner of such securities, and such beneficial ownership is expressly disclaimed. The filing of this statement should not be construed to be an admission that any of the Reporting Persons are members of a group for the purposes of Sections 13(d) and 13(g) of the Act.
| Item 5. | Ownership of Five Percent or Less of a Class. |
Not Applicable
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable
| Item 7. | Identification and Classification of the Subsidiary That Acquired the Security Being Reported by the Parent Holding Company or Control Person. |
Squadron Capital LLC is the record owner of 5,378,441 shares of the Issuer reported in this Schedule 13G, including 1,340 shares of Common Stock issuable upon exercise of options to purchase shares of Common Stock. Squadron Capital LLC is a wholly-owned subsidiary of Squadron Capital Holdings LLC.
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable
| Item 9. | Notice of Dissolution of the Group. |
Not Applicable
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 9 of 11 |
| Item 10. | Certification: |
Not Applicable
| Exhibits 99.1 | Joint Filing Agreement among Squadron Capital LLC, Squadron Capital Holdings LLC, Harry B. Rosenberg, not individually, but solely in his capacity as co-Trustee of the trusts identified in Item 4 of the Report and Charles E. Dobrusin, not individually, but solely in his capacity as co-Trustee of the trusts identified in Item 4 of the Report. |
| CUSIP No. 68752L100 | SCHEDULE 13G | Page 10 of 11 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: February 13, 2018 | Squadron Capital LLC | |||||
| By: | /s/ David R. Pelizzon | |||||
| Name: | David R. Pelizzon | |||||
| Title: | President | |||||
| Date: February 13, 2018 | Squadron Capital Holdings LLC | |||||
| By: | /s/ Charles E. Dobrusin | |||||
| Name: | Charles E. Dobrusin | |||||
| Title: | Co-Manager | |||||
| Date: February 13, 2018 | Harry B. Rosenberg, not individually, but solely in his capacity as co-Trustee of the trusts identified in Item 4 of this Report | |||||
| /s/ Harry B. Rosenberg | ||||||
| Date: February 13, 2018 | Charles E. Dobrusin, not individually, but solely in his capacity as co-Trustee of the trusts identified in Item 4 of this Report | |||||
| /s/ Charles E. Dobrusin | ||||||
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the foregoing Statement on Schedule 13G with respect to the common shares of OrthoPediatrics Corp. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts and all such counterparts taken together shall constitute one and the same instrument.
| Date: February 13, 2018 | Squadron Capital LLC | |||||
| By: | /s/ David R. Pelizzon | |||||
| Name: | David R. Pelizzon | |||||
| Title: | President | |||||
| Date: February 13, 2018 | Squadron Capital Holdings LLC | |||||
| By: | /s/ Charles E. Dobrusin | |||||
| Name: | Charles E. Dobrusin | |||||
| Title: | Co-Manager | |||||
| Date: February 13, 2018 | Harry B. Rosenberg, not individually, but solely as his capacity as co-Trustee of the trusts identified in Item 4 of the Report | |||||
| /s/ Harry B. Rosenberg | ||||||
| Date: February 13, 2018 | Charles E. Dobrusin, not individually, but solely as his capacity as co-Trustee of the trusts identified in Item 4 of the Report | |||||
| /s/ Charles E. Dobrusin | ||||||